2,037
5
Essay, 1 pages (100 words)

Corrigendum: successful use of human ab serum to support the expansion of adipose tissue-derived mesenchymal stem/stromal cell in a microcarrier-based platform

A Corrigendum on

by Moreira, F., Mizukami, A., de Souza, L. E. B., Cabral, J. M. S., da Silva, C. L., Covas, D. T., et al. (2020). Front. Bioeng. Biotechnol. 8: 307. doi:

In the published article, the affiliation of Joaquim M. S. Cabral and Cláudia L. da Silva is incorrect. The correct affiliation for both authors is:

1 Department of Bioengineering, Instituto Superior Técnico, iBB-Institute for Bioengineering and Biosciences, Universidade de Lisboa, Lisbon, Portugal

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Thank's for Your Vote!
Corrigendum: successful use of human ab serum to support the expansion of adipose tissue-derived mesenchymal stem/stromal cell in a microcarrier-based platform. Page 1
Corrigendum: successful use of human ab serum to support the expansion of adipose tissue-derived mesenchymal stem/stromal cell in a microcarrier-based platform. Page 2

This work, titled "Corrigendum: successful use of human ab serum to support the expansion of adipose tissue-derived mesenchymal stem/stromal cell in a microcarrier-based platform" was written and willingly shared by a fellow student. This sample can be utilized as a research and reference resource to aid in the writing of your own work. Any use of the work that does not include an appropriate citation is banned.

If you are the owner of this work and don’t want it to be published on AssignBuster, request its removal.

Request Removal
Cite this Essay

References

AssignBuster. (2022) 'Corrigendum: successful use of human ab serum to support the expansion of adipose tissue-derived mesenchymal stem/stromal cell in a microcarrier-based platform'. 2 January.

Reference

AssignBuster. (2022, January 2). Corrigendum: successful use of human ab serum to support the expansion of adipose tissue-derived mesenchymal stem/stromal cell in a microcarrier-based platform. Retrieved from https://assignbuster.com/corrigendum-successful-use-of-human-ab-serum-to-support-the-expansion-of-adipose-tissue-derived-mesenchymal-stemstromal-cell-in-a-microcarrier-based-platform/

References

AssignBuster. 2022. "Corrigendum: successful use of human ab serum to support the expansion of adipose tissue-derived mesenchymal stem/stromal cell in a microcarrier-based platform." January 2, 2022. https://assignbuster.com/corrigendum-successful-use-of-human-ab-serum-to-support-the-expansion-of-adipose-tissue-derived-mesenchymal-stemstromal-cell-in-a-microcarrier-based-platform/.

1. AssignBuster. "Corrigendum: successful use of human ab serum to support the expansion of adipose tissue-derived mesenchymal stem/stromal cell in a microcarrier-based platform." January 2, 2022. https://assignbuster.com/corrigendum-successful-use-of-human-ab-serum-to-support-the-expansion-of-adipose-tissue-derived-mesenchymal-stemstromal-cell-in-a-microcarrier-based-platform/.


Bibliography


AssignBuster. "Corrigendum: successful use of human ab serum to support the expansion of adipose tissue-derived mesenchymal stem/stromal cell in a microcarrier-based platform." January 2, 2022. https://assignbuster.com/corrigendum-successful-use-of-human-ab-serum-to-support-the-expansion-of-adipose-tissue-derived-mesenchymal-stemstromal-cell-in-a-microcarrier-based-platform/.

Work Cited

"Corrigendum: successful use of human ab serum to support the expansion of adipose tissue-derived mesenchymal stem/stromal cell in a microcarrier-based platform." AssignBuster, 2 Jan. 2022, assignbuster.com/corrigendum-successful-use-of-human-ab-serum-to-support-the-expansion-of-adipose-tissue-derived-mesenchymal-stemstromal-cell-in-a-microcarrier-based-platform/.

Get in Touch

Please, let us know if you have any ideas on improving Corrigendum: successful use of human ab serum to support the expansion of adipose tissue-derived mesenchymal stem/stromal cell in a microcarrier-based platform, or our service. We will be happy to hear what you think: [email protected]